Skip to main content

Treatment

EMTT: Extracorporeal Magnetotransduction Therapy

EMTT (extracorporeal magnetotransduction therapy) delivers a pulsed, high-intensity magnetic field into joint and tendon-attachment tissue. At Novo Soft Tissue in Centennial, it is one of four treatment tools. We use it only when the exam supports it.

Last reviewed: · Reviewed by Dr. Scott King, DC

The treatment

What Is EMTT?

Extracorporeal magnetotransduction therapy (EMTT) delivers a high-intensity, rapidly oscillating magnetic field through a loop applicator into a volume of tissue. The changing field induces a secondary electrical field inside the tissue.

EMTT is not shockwave. ESWT is a mechanical pressure pulse. EMTT is electromagnetic, with no mechanical pulse.

How EMTT Differs From ESWT

The two differ in energy type, sensation, reach, and proposed mechanism.

ESWT (Focused/Radial) EMTT
EnergyAcoustic pressure waveOscillating magnetic field
SensationMechanical impact, often feltUsually painless, no mechanical pulse
ReachSet by focal depth or decays from the applicatorPenetrates broadly through a treatment volume
Proposed effectMechanotransduction — fibroblast/ECM remodeling, cavitation-driven neovascularizationElectrotransduction — VEGF-driven angiogenesis, anti-inflammatory signaling, cellular metabolism

Because they work through different mechanisms, they are often paired. ESWT treats a discrete mechanical target, such as a tendon insertion or a fibrotic band. EMTT treats a broader degenerative or inflamed joint volume, where a focused mechanical pulse may not suit.

Mechanism

How It Works

The physics are the same as pulsed electromagnetic field (PEMF) therapy, at far higher intensity. EMTT devices typically run around 80 millitesla, roughly 10–80 times the field strength of a standard PEMF unit. The induced field is thought to raise VEGF (vascular endothelial growth factor), which promotes local blood flow, and to modulate inflammatory signaling.

These proposed effects come mainly from laboratory and early clinical research. They describe how EMTT might act on tissue; they are not direct proof of benefit for an individual patient.

For related cellular research on shockwave therapy in knee OA, see Cellular Senescence, Adhesion, and Shockwave.

Indications

When We May Use It

We use EMTT where the evidence points: degenerative and inflamed joint tissue and enthesis pain. The Hollander trial directly studied knee osteoarthritis, rotator cuff enthesopathy, and lumbar spondyloarthrosis (facet-joint driven low back pain).

EMTT does not replace treatment of a mechanically adhered tendon or fascia. Focused or radial ESWT and manual release are used for that.

We pair EMTT with focused ESWT when the problem sits in a joint or a deep muscle compartment, not at a single, accessible tendon insertion. It is not a default add-on to every visit.

For how EMTT fits into an exam-first knee plan, see knee osteoarthritis treatment. For the shoulder, see rotator cuff and shoulder pain treatment. For the low back, see chronic low back pain treatment.

EMTT Alone or With Shockwave? → · See how EMTT fits with our other treatments →

Precautions

When We May Not Use It

We screen for these at your exam. Any of them can rule EMTT out or change the plan:

  • A pacemaker, defibrillator, or other implanted electronic device
  • Metal implants in the treatment area
  • Pregnancy
  • Cancer in the treatment area

Another approach comes first when:

  • a tendon rupture or significant tear is suspected
  • a fracture or stress fracture is possible
  • numbness, tingling or weakness is progressing
  • the pain pattern points to a joint, spinal or medical problem that needs imaging or referral

Evidence

What the Evidence Shows

Best current evidence

The best current evidence is a 2026 double-blind, sham-controlled randomized trial by Hollander and colleagues in the Journal of Back and Musculoskeletal Rehabilitation. It included 126 patients with knee osteoarthritis (31), rotator cuff enthesopathy (43), or lumbar spondyloarthrosis (52). They received eight weekly EMTT sessions (80 mT, 8 Hz, 10,000 pulses per session) or an identical-feeling sham.

At 12 weeks, the EMTT group reported significantly less pain (VAS 2.2 vs. 4.2, p<0.001) and better physical function (SF-12 PCS 45.5 vs. 38.7, p<0.001) than sham. Mental-health scores did not differ between groups.

Alongside shockwave

In rotator cuff problems, an 86-patient trial found that adding EMTT to shockwave reduced pain more at 24 weeks than shockwave with sham EMTT (Klüter, 2018).

What is not yet known

The trial has real limits. Follow-up stopped at 12 weeks. There were no imaging or biomarker endpoints. It was a single-center trial with a mixed patient population.

Blinding was imperfect. In the active group, 59% correctly guessed their treatment, and 46% did in the sham group. Mild discomfort and skin redness were more common with active treatment. Any pain-outcome trial like this includes a real placebo response.

The authors note there is not yet a body of systematic reviews on EMTT, as there is for ESWT. This is one well-designed, sham-controlled trial: good evidence, not exhaustive evidence.

Sources: Hollander et al., Journal of Back and Musculoskeletal Rehabilitation, 2026 — PubMed · Full text on Sage · Klüter et al., Electromagn Biol Med 2018

What to expect

What Treatment Feels Like

EMTT treatment using the Storz Medical Magnetolith device
  • A session takes about 15–20 minutes and is billed as a standard follow-up visit.
  • The loop applicator rests over the treatment area. Most patients do not feel EMTT the way they feel shockwave.
  • Novo uses the Storz Magnetolith Ultra+.
  • We re-measure range of motion and strength at most visits to track change.

Usually 6–8 sessions, one week apart. The exact number depends on your diagnosis. EMTT is often paired with focused shockwave or manual adhesion release.

Treatment selection

How Novo Decides Whether to Use It

EMTT is not selected in advance, and it is not a default add-on to every visit. We first determine which tissue appears to be contributing to the problem and whether it is a joint, a tendon attachment or a muscle layer. Each tool has a different role:

  • Focused shockwave: a small or deep target, such as a tendon insertion or calcific deposit.
  • Radial shockwave: a broader, more superficial area of muscle, fascia or tendon.
  • EMTT: a joint or a deeper, broader tissue volume where a mechanical pulse may not suit.
  • Manual treatment: restricted muscle or fascia found by hand.
  • Load modification and exercise: part of most tendon and muscle care, with or without a device.
  • Imaging or referral: when the exam points to a tear, fracture, nerve compromise or a medical cause.

Some problems need one of these, some need a combination, and some need none of them. You do not need to choose a treatment before your visit.

Frequently Asked Questions

What is EMTT and how does it differ from shockwave therapy (ESWT)?

EMTT (extracorporeal magnetotransduction therapy) sends a high-intensity, rapidly oscillating magnetic field into a volume of tissue, which induces a secondary electrical field. ESWT works mechanically, as a pressure pulse. EMTT has no mechanical pulse, and most patients do not feel it the way they feel shockwave.

What conditions does EMTT treat?

Degenerative and inflamed joint tissue and enthesis pain. The trial evidence directly studied three conditions: knee osteoarthritis, rotator cuff enthesopathy, and lumbar spondyloarthrosis (facet-joint driven low back pain). EMTT does not replace treatment of an adhered tendon or fascia. Focused or radial ESWT and manual release are used for that.

How long is an EMTT session?

About 15-20 minutes.

How many EMTT sessions will I need?

Usually 6-8 sessions, one week apart. The exact number depends on your diagnosis.

Does EMTT hurt?

Usually not. There is no mechanical pulse, and most patients do not feel EMTT the way they feel shockwave.

Who should not have EMTT?

We screen for a pacemaker, defibrillator, or other implanted electronic device, metal implants in the treatment area, pregnancy, and cancer in the treatment area. Any of these can rule EMTT out or change the plan.

Does EMTT cost extra?

No. EMTT is usually part of a standard follow-up visit. Current prices are on the pricing page.

Your First Visit

The Exam Comes First

  • New patient exam

    $270. History, examination and an explanation of the findings. No treatment at the first visit.

  • Follow-up visits

    $90 for one region. Radial shockwave, EMTT and manual treatment are usually part of this visit.

  • Focused shockwave visits

    $180, only when the exam identifies a focused-shockwave target.

View pricing and payment options

Start With the Exam

Not sure whether EMTT is appropriate?

The first step is determining whether this treatment is appropriate. You do not need to choose a treatment before you come in.

Questions? Call 720.502.6468

6059 S. Quebec St., Suite 203 Centennial, CO 80111
Tue & Thu 12–5pm Wed & Fri 6:30–11am

Exam-first care for muscle, tendon, fascia, and joint pain in the Denver Tech Center.

Call Book an Exam